Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:51 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 241–264 of 362 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Electrocardiogram (ECG) Clear all

Conditions: Inpatients and Outpatients With Routine 12-lead ECG
Interventions: Not listed
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cirrhosis
Interventions: ACE (AI-Cirrhosis-ECG) 2.0; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 248 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Prematurity
Interventions: Apparatuses; Device
Lead sponsor: University of Oklahoma; Other
Eligibility: Up to 20 Minutes
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Atrial Fibrillation (AF), Arrhythmias Cardiac, Tachycardia, Palpitations, Bradycardia
Interventions: Atrial Fibrillation Identification; Diagnostic Test
Lead sponsor: Everbeat; Industry
Eligibility: 18 Years and older
Enrollment: 232 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 3
States / cities: La Jolla, California • Baton Rouge, Louisiana • Pittsburgh, Pennsylvania

Conditions: Hypoglycemia, Cognition
Interventions: Cognitive Assessment (not diagnostic), ECG; Other · Diagnostic Test
Lead sponsor: Joslin Diabetes Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 22 participants
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypertension, Sleep Disorder, Healthy
Interventions: 24 hour blood pressure (BP) monitoring, Polysomnography; Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 70 Years
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Hemodynamic Effects of Energy Drink, Electrocardiograph Effects of Energy Drinks
Interventions: Energy Drink, Active Control; Dietary Supplement
Lead sponsor: David Grant U.S. Air Force Medical Center; Federal
Eligibility: 18 Years to 40 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Travis Air Force Base, California

Conditions: Healthy Subjects
Interventions: Exenatide, Moxifloxacin, Placebo comparator; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 94 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 2
States / cities: Daytona Beach, Florida • Evansville, Indiana

Conditions: Sudden Cardiac Arrest
Interventions: 12 lead Electrocardiogram; Diagnostic Test
Lead sponsor: Heartstream US LLC; Industry
Eligibility: 29 Days to 89 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Lehigh Acres, Florida

Conditions: Atrial Fibrillation Paroxysmal, Atrial Fibrillation, Persistent, Cardiac Arrhythmia, Ablation
Interventions: Holter monitoring in patients who have been successfully implanted with an Abbott Assert-IQ ICM device; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 151 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 11
States / cities: San Diego, California • Orlando, Florida • Overland Park, Kansas + 8 more

Conditions: Electrocardiography
Interventions: Electrocardiogram holter; Device
Lead sponsor: University of Toledo Health Science Campus; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Toledo, Ohio

Conditions: B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
Interventions: Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration and Biopsy, Cyclophosphamide, Cytarabine, Dasatinib, Dexamethasone, Doxorubicin Hydrochloride, Echocardiography Test, Electrocardiography, Lumbar Puncture, Mesna, Methotrexate, Multigated Acquisition Scan, Ponatinib Hydrochloride, Prednisone, Vincristine Sulfate; Procedure · Biological · Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 75 Years
Enrollment: 348 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 207
States / cities: Birmingham, Alabama • Anchorage, Alaska • Fort Smith, Arkansas + 145 more

Conditions: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder
Interventions: 24 Holter Monitor Recording; Device
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: ECG, Electrocardiography, Monitoring, Physiologic
Interventions: Chest-Worn ECG Monitoring Device; Device
Lead sponsor: Perin Health Devices; Industry
Eligibility: 22 Years to 90 Years
Enrollment: 255 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Woodland Hills, California

Conditions: PreTerm Labor, Threatened Preterm Labor, Preterm Birth
Interventions: Uterine electromyography; Device
Lead sponsor: PreTeL, Inc; Industry
Eligibility: Female only
Enrollment: 181 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Rochester, New York • Durham, North Carolina

Conditions: Arrhythmogenic Right Ventricular Cardiomyopathy, Arrhythmogenic Right Ventricular Dysplasia, Arrhythmogenic Ventricular Cardiomyopathy, Arrhythmogenic Cardiomyopathy, Ventricular Tachycardia, Sudden Cardiac Death
Interventions: ECG, Echocardiography, Cardiac MRI, Ambulatory ECG recording, Cardiac EP study, All study subjects will undergo sample collection for genetic testing.; Diagnostic Test · Genetic
Lead sponsor: Sheri Kashmir Institute of Medical Sciences; Other
Eligibility: Not listed
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Multiple Myeloma
Interventions: 64Cu-LLP2A, PET/MR, Blood samples for serum stability, Blood samples for metabolite analysis, Urine sample, Tumor biopsy, Electrocardiogram, PET/CT; Drug · Device · Procedure
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: No Specific Medical Conditions or Disease States
Interventions: Telemetry monitoring; Device
Lead sponsor: Turtle Shell Technologies Pvt. Ltd.; Industry
Eligibility: 22 Years to 100 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Lake Jackson, Texas

Conditions: Healthy Subjects
Interventions: Mellaril; Drug
Lead sponsor: New Mexico Cancer Research Alliance; Other
Eligibility: 18 Years to 55 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Ventricular Tachycardia
Interventions: Ventricular Tachycardia Ablation, ICD Implant, Antiarrhythmic drug, EKG, Cardioversion, Echocardiogram; Procedure · Device · Drug + 1 more
Lead sponsor: CorVita Science Foundation; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2030
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Acute Coronary Syndrome
Interventions: Multifunction Cardiogram; Device
Lead sponsor: Tampa General Hospital; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Neonatal Resuscitation, Infant, Premature
Interventions: Electrocardiogram group, Pulse oximeter and auscultation group; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: Up to 1 Hour
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Coronary Artery Disease
Interventions: CardioPET; Drug
Lead sponsor: Fluoropharma, Inc.; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Mesothelioma
Interventions: LMB-100, ipilimumab, Diphenhydramine, Famotidine, Acetaminophen, Dexamethasone, Biopsy, FDG-PET, CT CAP, MRI, ECG, Echocardiogram; Biological · Drug · Procedure + 1 more
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

Personalized Risk Identification and Management for Arrhythmias and Heart Failure by ECG and MRI

A Study to Detect Advanced Liver Disease Via AI-enabled Electrocardiogram

Electrocardiography Versus Pulse Oximetry for Newborn Heart Rate Determination

Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring

Cognition in Patients With Hypoglycemia, Without Diabetes

Study of Disrupted Sleep in Somali Americans

Evaluation of Energy Drink Consumption on ECG and Hemodynamic Parameters in Young Healthy Volunteers

A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjects

The Intrepid Clinical Engineering Study

Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study

Clinical Comparison of Electrocardiograms Collected Using an Ambulatory Holter

Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment

Validation of Perin Health Patch ECG Monitoring Device Performance and Placement Accuracy

Labor Status Monitor for Diagnosing True vs False Labor in Preterm Patients

South Asian Arrhythmogenic Cardiomyopathy Registry

64Cu-LLP2A for Imaging Multiple Myeloma

Dozee Validation for Contactless Heart Rate and Respiration Monitoring in Clinical Settings

Feasibility of Thioridazine as a Mobilizing Agent for CD34+ Hematopoietic Progenitor Cells

MANAGE-VT Registry - MANAGEment of Ventricular Tachycardia Outcomes Registry

Emergency Department MCG for Suspected Acute Coronary Syndrome

Heart Rate Evaluation and Resuscitation Trial in Preterm Neonates

A Phase I Study in Healthy Volunteers to Evaluate the Safety of CardioPET™ in Detection of Coronary Artery Disease

Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma